The vaccine advisory committee for the Food and Drug Administration met Thursday to discuss potential changes to the formula for COVID-19 vaccines for 2025-2026.

WASHINGTON (AP) — A government report released on Thursday covering wide swaths of American health and wellness reflects some ...

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make a broad recommendation about which lineage of the coronavirus should be ...

The U.S. government has not yet made its official recommendations for who should be able to get COVID booster shots this fall ...

An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...

Government advisers are meeting Thursday to decide if COVID-19 vaccines need updating to improve protection this fall and ...

U.S. senators questioned the head of the FDA today about who will be eligible for a COVID-19 booster in the fall. The agency now plans to restrict access to many Americans ...

Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...

The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...